Package 31722-165-31

Brand: fosaprepitant

Generic: fosaprepitant dimeglumine
NDC Package

Package Facts

Identity

Package NDC 31722-165-31
Digits Only 3172216531
Product NDC 31722-165
Product ID 31722-165_014f00f9-34a5-4aca-e063-6294a90a1019
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-07-29
Brand fosaprepitant
Generic fosaprepitant dimeglumine
Sample Package No

Linked Drug Pages (1)

Fosaprepitant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "014f00f9-34a5-4aca-e063-6294a90a1019", "openfda": {"upc": ["0331722165310"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["7dbdf8f5-6936-4143-b52d-96774b799a7d"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "31722-165-31", "marketing_start_date": "20210729"}], "brand_name": "Fosaprepitant", "product_id": "31722-165_014f00f9-34a5-4aca-e063-6294a90a1019", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "31722-165", "generic_name": "Fosaprepitant dimeglumine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA214616", "marketing_category": "ANDA", "marketing_start_date": "20210729", "listing_expiration_date": "20261231"}